Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6532586rdf:typepubmed:Citationlld:pubmed
pubmed-article:6532586lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:6532586lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:6532586lifeskim:mentionsumls-concept:C0700219lld:lifeskim
pubmed-article:6532586lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:6532586lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:6532586pubmed:issue10-11lld:pubmed
pubmed-article:6532586pubmed:dateCreated1985-6-20lld:pubmed
pubmed-article:6532586pubmed:abstractTextIn a study carried-out in double-blind fashion it was possible to demonstrate that skin vasoconstriction induced by cigarette smoking in normal volunteers is due to a concomitant enhancement of arginine vasopressin release. The skin blood flow reduction occurring after smoking was indeed more pronounced in the subjects reaching the highest levels of arginine vasopressin and this effect was curtailed by the administration of a specific vasopressin antagonist acting at the vascular site.lld:pubmed
pubmed-article:6532586pubmed:languageenglld:pubmed
pubmed-article:6532586pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6532586pubmed:citationSubsetIMlld:pubmed
pubmed-article:6532586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6532586pubmed:statusMEDLINElld:pubmed
pubmed-article:6532586pubmed:issn0730-0077lld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:NussbergerJJlld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:BrunnerH RHRlld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:WaeberBBlld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:HofbauerK GKGlld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:SchallerM DMDlld:pubmed
pubmed-article:6532586pubmed:authorpubmed-author:BussienJ PJPlld:pubmed
pubmed-article:6532586pubmed:issnTypePrintlld:pubmed
pubmed-article:6532586pubmed:volume6lld:pubmed
pubmed-article:6532586pubmed:ownerNLMlld:pubmed
pubmed-article:6532586pubmed:authorsCompleteYlld:pubmed
pubmed-article:6532586pubmed:pagination2003-6lld:pubmed
pubmed-article:6532586pubmed:dateRevised2008-2-12lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:meshHeadingpubmed-meshheading:6532586-...lld:pubmed
pubmed-article:6532586pubmed:year1984lld:pubmed
pubmed-article:6532586pubmed:articleTitleSkin blood flow and cigarette smoking: the role of vasopressin.lld:pubmed
pubmed-article:6532586pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6532586pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:6532586pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:6532586pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed